Sign In
Free Newsletter
Novartis reports progress on $23B US manufacturing expansion
Novartis advances its $23B U.S. manufacturing plan, expanding R&D and drug production as it aims to produce key medicines domestically.
Trump 100% pharma tariffs raise concerns for New Jersey life sciences (updated)
The president's levies on imported drugs and ingredients raise concerns for New Jersey’s life sciences sector, with risks to costs and innovation.
NJ joins multistate lawsuit against Trump’s new tariffs
New Jersey is one of more than 20 states suing the Trump administration over 15% tariffs, claiming unlawful authority and higher costs for consumers and businesses.
Poll: 2 in 3 NJ voters say Trump tariffs raised prices
A Stockton University poll finds two-thirds of NJ voters say Trump administration tariffs raised prices, with sharp partisan divides on trade policy.
Supreme Court strikes down Trump tariffs
The 6–3 ruling found that the president lacked IEEPA authority for the levies, drawing reaction from Gov. Mikie Sherrill and New Jersey business leaders.
JPMorganChase outlook: NJ businesses expect growth in 2026
JPMorganChase’s 2026 survey results show local owners expect revenue growth, hiring gains and innovation in the year ahead, despite inflation, tariffs and uncertainty.
NJBIZ panel weighs tariffs, power and growth in NJ construction
Experts from Rockefeller Group, Gibbons PC and Hackensack Meridian Health discuss challenges facing builders and developers in New Jersey.
NJBIZ construction panel digs into tariffs, power costs
Experts examine how the Trump administration's levies are affecting the industry, workforce challenges, the overall lending landscape and more.
NJBIA survey: Energy costs, tariffs top NJ business challenges
The annual poll found that 77% of respondents were affected by increased power bills and 49% said trade levies impacted their supply chains this year.
US, UK finalize pharma pricing deal to boost innovation
The agreement raises United Kingdom payments for medicines, easing cost pressures domestically as well as strengthening United States life sciences investment.
Arizona opens immersive factory tour in Keasbey
"ArizonaLand" features a free, inside look at the plant, offering samples, exhibits and more across the 70-acre campus.
Trump drug tariff draws backlash from NJ pharma industry
New Jersey’s pharmaceutical leaders warn the president's proposed levy could raise costs, disrupt supply chains and hurt patient access.
